Amyloid Treatments | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Amyloid Treatments

key information

source: Boston University School of Medicine

year: 2012

summary/abstract:

Amyloidosis is a serious condition in which a protein known as amyloidosis is accumulated in various parts of the body leading to various complications. Treatment of this disease depends upon the type, location and severity of the disease. Since amyloidosis is a rare disease, its treatment options are still evolving and some are under clinical trials. 
 
For the treatment of this disease, various drugs are used but it is not mandatory that if these drugs work effectively on one patient, it will have the same effect on others too. 
 
For treatment of primary amyloidosis, various techniques and medications are used to eliminate extra protein from the bone marrow. Chemotherapy with certain drugs, steroids and many more are used to manage this disease. In Familial amyloidosis, a patient should not receive chemotherapy. Patient with secondary amyliodosis complain majorly about liver problem and hence liver transplant is the best option for them. 
 
These treatment options are very individual and are given to a patient after considering his age, organ involved, severity, patient and doctor preferrence. 
 
read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close